Insights Into Improving Diagnosis and Treatment of IPF

You are here

Contact Us

Have a comment, complaint, or compliment? We want to hear from you.

Your E-mail *

Your Name *

Message *

Required *

In recent years, a greater understanding of the natural progression of idiopathic pulmonary fibrosis (IPF) has provided clarity as to the importance of an early and accurate diagnosis. Patients experiencing delayed diagnosis are subjected to increasing morbidity and mortality. Fortunately, there are now a number of patient-oriented and evidence-based strategies that allow clinicians to effectively manage patients with IPF. These pharmacological and nonpharmacological strategies allow clinicians to improve patient outcomes by reducing the rate of lung function decline and possibly, increasing patient survival. However, in order to truly optimise patient outcomes, a patient-centred, multidisciplinary approach will need to be implemented. This site seeks to provide clinicians with resources that will showcase the evolving knowledge of evidence-based strategies to improve early diagnosis and treatment of IPF.

*This is an independent, educational site made possible through financial support from F. Hoffmann-La Roche Ltd. All written agreements clearly stipulate and enforce the editorial independence of PeerVoice and the contributing faculty.

This site may contain discussions of unapproved products or uses of these products in certain jurisdictions. Where applicable, faculty have been advised to disclose any reference to an unlabelled or unapproved use.

This site is intended for healthcare professionals only. The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerVoice or any of its supporters.